US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist

45.110
+1.760+4.06%

Close May 3 16:00 ET

45.400
+0.290+0.64%

Post 19:41 ET

3.34BMarket Cap-8759P/E (TTM)

SpringWorks Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-27.68%-78.93M

-37.90%-222.8M

-15.69%-62.71M

-157.40%-50.46M

-22.37%-47.81M

-26.97%-61.82M

-26.34%-161.56M

-17.02%-54.2M

27.20%-19.6M

-16.53%-39.07M

Net income from continuing operations

-19.02%-87.39M

-17.19%-325.1M

-27.16%-94.32M

-9.74%-79.44M

-12.85%-77.93M

-18.80%-73.42M

-59.52%-277.42M

-32.29%-74.18M

-76.38%-72.39M

-46.88%-69.05M

Operating gains losses

-19.80%1.03M

74.33%5.04M

169.85%1.84M

-31.09%1.02M

132.82%901K

279.23%1.28M

192.51%2.89M

125.91%680K

456.55%1.49M

143.40%387K

Depreciation and amortization

188.14%729K

117.91%1.67M

110.98%538K

133.02%494K

101.05%382K

134.26%253K

56.12%765K

74.66%255K

78.15%212K

65.22%190K

Other non cash items

39.86%400K

46.15%1.65M

66.78%477K

53.50%439K

57.14%451K

5.15%286K

13.90%1.13M

15.32%286K

17.70%286K

17.14%287K

Change In working capital

-77.52%-24.16M

-101.53%-583K

2,315.57%3.7M

-87.85%3.92M

-49.41%5.41M

-189.70%-13.61M

644.49%38.1M

94.08%-167K

1,064.99%32.28M

156.38%10.69M

-Change in receivables

---9.6M

---5.93M

----

--0

----

-Change in inventory

---2.11M

---3.1M

----

--0

----

-Change in prepaid assets

8.89%-1.79M

-375.60%-5.13M

-23.09%-2.71M

-231.03%-2.77M

945.95%2.32M

-213.82%-1.97M

140.38%1.86M

48.84%-2.2M

338.33%2.11M

300.00%222K

-Change in payables and accrued expense

9.07%-10.01M

-10.19%15.71M

474.69%16.03M

-27.75%7.59M

-70.91%3.1M

-70.27%-11.01M

45.95%17.49M

25.35%2.79M

148.09%10.5M

148.54%10.67M

-Change in other current assets

67.90%-78K

-1,473.77%-838K

22.05%-152K

-304.27%-478K

158.33%35K

-396.34%-243K

108.63%61K

24.42%-195K

200.86%234K

-118.29%-60K

-Change in other current liabilities

-45.27%-568K

-50.52%-1.29M

22.94%-430K

-275.68%-417K

62.33%-55K

-788.64%-391K

44.65%-859K

-16.25%-558K

67.54%-111K

57.31%-146K

-Change in other working capital

----

--19.55M

--1K

----

Cash from discontinued investing activities

Operating cash flow

-27.68%-78.93M

-37.90%-222.8M

-15.69%-62.71M

-157.40%-50.46M

-22.37%-47.81M

-26.97%-61.82M

-26.34%-161.56M

-17.02%-54.2M

27.20%-19.6M

-16.53%-39.07M

Investing cash flow

Cash flow from continuing investing activities

-78.23%21.46M

116.12%34.75M

55.15%-159.21M

-59.88%34.6M

127.07%60.76M

273.16%98.6M

-357.92%-215.6M

-731.90%-355.01M

140.97%86.23M

18.69%26.76M

Capital expenditure reported

80.62%-577K

27.57%-7.39M

231.09%2.3M

-2.66%-3.62M

-22.30%-3.09M

-24.72%-2.98M

-405.75%-10.2M

-16.76%-1.76M

-953.13%-3.53M

-1,812.88%-2.53M

Net business purchase and sale

-194.11%-8.24M

33.33%-2.8M

--0

---2.8M

---4.2M

--0

---4.2M

Net investment purchase and sale

-71.00%30.28M

122.34%44.94M

54.28%-161.51M

-57.42%38.22M

90.68%63.84M

262.30%104.38M

-335.03%-201.2M

-712.38%-353.25M

148.50%89.76M

47.65%33.48M

Cash from discontinued investing activities

Investing cash flow

-78.23%21.46M

116.12%34.75M

55.15%-159.21M

-59.88%34.6M

127.07%60.76M

273.16%98.6M

-357.92%-215.6M

-731.90%-355.01M

140.97%86.23M

18.69%26.76M

Financing cash flow

Cash flow from continuing financing activities

70.13%-552K

-12.93%296.64M

100,259.40%299.07M

-100.07%-242K

-288.64%-342K

-808.05%-1.85M

29,347.02%340.7M

22.13%298K

79,954.35%340.23M

-168.22%-88K

Net common stock issuance

-236.46%-6.5M

-12.47%296.5M

--299.05M

-100.08%-264K

-57.85%-352K

-113.13%-1.93M

--338.73M

--0

--339.85M

---223K

Proceeds from stock option exercised by employees

7,062.65%5.95M

-92.97%139K

-91.95%24K

-94.16%22K

-92.59%10K

-92.89%83K

70.87%1.98M

22.13%298K

-11.29%377K

4.65%135K

Cash from discontinued financing activities

Financing cash flow

70.13%-552K

-12.93%296.64M

100,259.40%299.07M

-100.07%-242K

-288.64%-342K

-808.05%-1.85M

29,347.02%340.7M

22.13%298K

79,954.35%340.23M

-168.22%-88K

Net cash flow

Beginning cash position

159.54%176.67M

-34.88%68.07M

-79.14%99.51M

64.87%115.61M

24.82%103.01M

-34.88%68.07M

-29.21%104.53M

405.18%476.98M

-17.64%70.12M

-14.03%82.52M

Current changes in cash

-266.06%-58.02M

397.87%108.6M

118.87%77.16M

-103.96%-16.1M

201.62%12.6M

258.79%34.94M

15.47%-36.46M

-4,145.03%-408.91M

4,283.78%406.86M

-14.25%-12.4M

End cash Position

15.18%118.65M

159.54%176.67M

-79.14%99.51M

64.87%115.61M

24.82%103.01M

-34.88%68.07M

405.18%476.98M

-17.64%70.12M

Free cash flow

-22.71%-79.51M

-34.01%-230.18M

-7.95%-60.4M

-133.80%-54.08M

-22.37%-50.9M

-26.86%-64.8M

-32.23%-171.76M

-17.01%-55.96M

15.16%-23.13M

-23.58%-41.6M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-27.68%-78.93M	-37.90%-222.8M	-15.69%-62.71M	-157.40%-50.46M	-22.37%-47.81M	-26.97%-61.82M	-26.34%-161.56M	-17.02%-54.2M	27.20%-19.6M	-16.53%-39.07M
Net income from continuing operations	-19.02%-87.39M	-17.19%-325.1M	-27.16%-94.32M	-9.74%-79.44M	-12.85%-77.93M	-18.80%-73.42M	-59.52%-277.42M	-32.29%-74.18M	-76.38%-72.39M	-46.88%-69.05M
Operating gains losses	-19.80%1.03M	74.33%5.04M	169.85%1.84M	-31.09%1.02M	132.82%901K	279.23%1.28M	192.51%2.89M	125.91%680K	456.55%1.49M	143.40%387K
Depreciation and amortization	188.14%729K	117.91%1.67M	110.98%538K	133.02%494K	101.05%382K	134.26%253K	56.12%765K	74.66%255K	78.15%212K	65.22%190K
Other non cash items	39.86%400K	46.15%1.65M	66.78%477K	53.50%439K	57.14%451K	5.15%286K	13.90%1.13M	15.32%286K	17.70%286K	17.14%287K
Change In working capital	-77.52%-24.16M	-101.53%-583K	2,315.57%3.7M	-87.85%3.92M	-49.41%5.41M	-189.70%-13.61M	644.49%38.1M	94.08%-167K	1,064.99%32.28M	156.38%10.69M
-Change in receivables	---9.6M	---5.93M	----	----	----	--0	--0	----	----	----
-Change in inventory	---2.11M	---3.1M	----	----	----	--0	--0	----	----	----
-Change in prepaid assets	8.89%-1.79M	-375.60%-5.13M	-23.09%-2.71M	-231.03%-2.77M	945.95%2.32M	-213.82%-1.97M	140.38%1.86M	48.84%-2.2M	338.33%2.11M	300.00%222K
-Change in payables and accrued expense	9.07%-10.01M	-10.19%15.71M	474.69%16.03M	-27.75%7.59M	-70.91%3.1M	-70.27%-11.01M	45.95%17.49M	25.35%2.79M	148.09%10.5M	148.54%10.67M
-Change in other current assets	67.90%-78K	-1,473.77%-838K	22.05%-152K	-304.27%-478K	158.33%35K	-396.34%-243K	108.63%61K	24.42%-195K	200.86%234K	-118.29%-60K
-Change in other current liabilities	-45.27%-568K	-50.52%-1.29M	22.94%-430K	-275.68%-417K	62.33%-55K	-788.64%-391K	44.65%-859K	-16.25%-558K	67.54%-111K	57.31%-146K
-Change in other working capital	----	----	----	----	----	----	--19.55M	--1K	----	----
Cash from discontinued investing activities
Operating cash flow	-27.68%-78.93M	-37.90%-222.8M	-15.69%-62.71M	-157.40%-50.46M	-22.37%-47.81M	-26.97%-61.82M	-26.34%-161.56M	-17.02%-54.2M	27.20%-19.6M	-16.53%-39.07M
Investing cash flow
Cash flow from continuing investing activities	-78.23%21.46M	116.12%34.75M	55.15%-159.21M	-59.88%34.6M	127.07%60.76M	273.16%98.6M	-357.92%-215.6M	-731.90%-355.01M	140.97%86.23M	18.69%26.76M
Capital expenditure reported	80.62%-577K	27.57%-7.39M	231.09%2.3M	-2.66%-3.62M	-22.30%-3.09M	-24.72%-2.98M	-405.75%-10.2M	-16.76%-1.76M	-953.13%-3.53M	-1,812.88%-2.53M
Net business purchase and sale	-194.11%-8.24M	33.33%-2.8M	--0	--0	--0	---2.8M	---4.2M	--0	--0	---4.2M
Net investment purchase and sale	-71.00%30.28M	122.34%44.94M	54.28%-161.51M	-57.42%38.22M	90.68%63.84M	262.30%104.38M	-335.03%-201.2M	-712.38%-353.25M	148.50%89.76M	47.65%33.48M
Cash from discontinued investing activities
Investing cash flow	-78.23%21.46M	116.12%34.75M	55.15%-159.21M	-59.88%34.6M	127.07%60.76M	273.16%98.6M	-357.92%-215.6M	-731.90%-355.01M	140.97%86.23M	18.69%26.76M
Financing cash flow
Cash flow from continuing financing activities	70.13%-552K	-12.93%296.64M	100,259.40%299.07M	-100.07%-242K	-288.64%-342K	-808.05%-1.85M	29,347.02%340.7M	22.13%298K	79,954.35%340.23M	-168.22%-88K
Net common stock issuance	-236.46%-6.5M	-12.47%296.5M	--299.05M	-100.08%-264K	-57.85%-352K	-113.13%-1.93M	--338.73M	--0	--339.85M	---223K
Proceeds from stock option exercised by employees	7,062.65%5.95M	-92.97%139K	-91.95%24K	-94.16%22K	-92.59%10K	-92.89%83K	70.87%1.98M	22.13%298K	-11.29%377K	4.65%135K
Cash from discontinued financing activities
Financing cash flow	70.13%-552K	-12.93%296.64M	100,259.40%299.07M	-100.07%-242K	-288.64%-342K	-808.05%-1.85M	29,347.02%340.7M	22.13%298K	79,954.35%340.23M	-168.22%-88K
Net cash flow
Beginning cash position	159.54%176.67M	-34.88%68.07M	-79.14%99.51M	64.87%115.61M	24.82%103.01M	-34.88%68.07M	-29.21%104.53M	405.18%476.98M	-17.64%70.12M	-14.03%82.52M
Current changes in cash	-266.06%-58.02M	397.87%108.6M	118.87%77.16M	-103.96%-16.1M	201.62%12.6M	258.79%34.94M	15.47%-36.46M	-4,145.03%-408.91M	4,283.78%406.86M	-14.25%-12.4M
End cash Position	15.18%118.65M	159.54%176.67M	159.54%176.67M	-79.14%99.51M	64.87%115.61M	24.82%103.01M	-34.88%68.07M	-34.88%68.07M	405.18%476.98M	-17.64%70.12M
Free cash flow	-22.71%-79.51M	-34.01%-230.18M	-7.95%-60.4M	-133.80%-54.08M	-22.37%-50.9M	-26.86%-64.8M	-32.23%-171.76M	-17.01%-55.96M	15.16%-23.13M	-23.58%-41.6M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall